Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 27, 2015 - Issue 5
135
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Acceptability of early anti-retroviral therapy among HIV-infected people in Anhui province in China

, , , , , & show all
Pages 669-674 | Received 22 May 2014, Accepted 21 Oct 2014, Published online: 26 Nov 2014

References

  • Badri, M., Cleary, S., Maartens, G., Pitt, J., Bekker, L. G., Orrell, C., & Wood, R. (2006). When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antiviral Therapy, 11, 63–72.
  • de Mulder, M., York, V. A., Wiznia, A. A., Michaud, H. A., Nixon, D. F., Holguin, A., & Rosenberg, M. G. (2013). HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. HIV Medicine, 15(3), 135–143. doi:10.1111/hiv.12089
  • Department of Public Health of Anhui Province. (2012). News release about AIDS prevention and control in Anhui province. Retrieved from http://www.ahwst.gov.cn/chn200909261718343%20/article.jsp?articleId=62321798
  • He, H. J., Xu, P., Xin, Q. Q., Zeng, J., Zhang, L. L., Sun, D. Y., … Lv, F. (2013). Investigation on condom use and its relative influencing factors among families with single-positive HIV infection. Chinese Journal of Disease Control and Prevention, 17, 392–395.
  • Heffron, R., Ngure, K., Mugo, N., Celum, C., Kurth, A., Curran, K., & Baeten, J. M. (2012). Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. JAIDS Journal of Acquired Immune Deficiency Syndromes, 61(1), 116–119. doi:10.1097/QAI.0b013e31825da73f
  • Jiang, H. H., Lü, F., He, H. J., Zhang, D. D., Zeng, G., Xu, P., … Pan, X. H. (2013). Acceptability status of early antiretroviral therapy among HIV-positive men who have sex with men. Zhonghua Yu Fang Yi Xue Za Zhi, 47, 843–847.
  • Muhamadi, L., Nsabagasani, X., Tumwesigye, M. N., Wabwire-Mangen, F., Ekström, A.-M., Peterson, S., & Pariyo, G. (2010). Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: Policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD < 350 cells/µL) in eastern Uganda. Health Policy, 97, 187–194. doi:10.1016/j.healthpol.2010.06.003
  • NCAIDS. (2014). Update on the AIDS/STD epidemic in china and main response in control and prevention in April, 2014. Chinese Journal of AIDS & STD, 20, 385.
  • Parkes-Ratanshi, R., Bufumbo, L., Nyanzi-Wakholi, B., Levin, J., Grosskurth, H., Lalloo, D. G., & Kamali, A. (2010). Barriers to starting ART and how they can be overcome: Individual and operational factors associated with early and late start of treatment Barriers to ART. Tropical Medicine and International Health, 15, 1347–1356. doi:10.1111/j.13653156.2010.02620.x
  • Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr, W. M., Lundgren, J., Neaton, J. D., Gordin, F., Abrams, D., … Rappoport, C. (2006). CD4+ Count–guided interruption of antiretroviral treatment. New England Journal of Medicine, 355, 2283–2296. doi:10.1056/NEJMoa062360
  • WHO. (2013). WHO issues new HIV recommendations calling for earlier treatment. Geneva: Author. Retrieved July 1, 2013, from http://www.who.int/mediacentre/news/releases/2013/new_hiv_recommendations_20130630/en/index.html.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.